Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
11/28/22 CinCor (CINC) Baxdrostat for Hypertension (Systemic) Subscribers Only Subscribers Only Subscribers Only
11/22/22 Merck (MRK) Keytruda for Gastric Cancer Subscribers Only Subscribers Only Subscribers Only
11/18/22 Lysogene (LYS:FP) LYS-SAF302 for Mucopolysaccharidosis IIIA (MPS IIIA; Sanfilippo A Syndrome) Subscribers Only Subscribers Only Subscribers Only
11/17/22 Astellas Pharma (4503:JP) Zolbetuximab for Gastric Cancer Subscribers Only Subscribers Only Subscribers Only
11/16/22 Mineralys MLS-101 for Hypertension (Systemic) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
11/29/22 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 11/30/22 Subscribers Only Subscribers Only Regulatory - Other
Now - 11/30/22 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Now - 11/30/22 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 11/30/22 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Back to the top Back to the top